首页 > 最新文献

Benha Veterinary Medical Journal最新文献

英文 中文
Prevalence and Associated Risk Factors of Mortality among COVID-19 Patients COVID-19患者的患病率及相关死亡危险因素
Pub Date : 2023-10-20 DOI: 10.21608/bmfj.2023.218712.1842
Ali Okab, Osama Mohammad, Basma Hany, Doaa Afifi, Rehab Elsawy
{"title":"Prevalence and Associated Risk Factors of Mortality among COVID-19 Patients","authors":"Ali Okab, Osama Mohammad, Basma Hany, Doaa Afifi, Rehab Elsawy","doi":"10.21608/bmfj.2023.218712.1842","DOIUrl":"https://doi.org/10.21608/bmfj.2023.218712.1842","url":null,"abstract":"","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic factors affecting the surgical outcome of secondary hydrocephalus in infants 影响婴儿继发性脑积水手术结果的预后因素
Pub Date : 2023-10-20 DOI: 10.21608/bmfj.2023.234928.1894
Mohamed Elmaghrabi, Waleed Badawy, Mohammed Eltantawy, Heba Abdelhady, Shawky Elmeleigy
: Background: Acquired Hydrocephalus can develop at birth or in adulthood. It has many etiologies like obstruction by Tumors, inflammatory and infective lesions like meningioencephalitis and cerebral abscess. It may result from Hemorrhage like parenchymal hemorrhage, intra-ventricular hemorrhage, germinal matrix hemorrhage(GMH). GMH is the leading cause of acquired infantile hydrocephalus in preterms. But still the main causes of secondary hydrocephalus in the infantile age groups post-meningetic and post hemorrhagic. Aim: the aim of this study is to evaluate the different prognostic factors affecting the clinical and surgical outcome in cases of secondary hydrocephalus in infants. Methods: This is a prospective study conducted on 30 non-consecutive cases with secondary hydrocephalus who underwent surgery by variable surgical procedures at Benha University Hospital from March 2022 to June 2023. Results: The mean age of the included patients was 11.43 months. The distribution of underlying pathology of studied cases was (Post-meningetic 80%, Post-hemorrhagic 13.3%, Post-tumor 6.7%). Cases were followed up for 6-12 months. There was reported incidence of favorable clinical and surgical outcome of 60 % of cases with no need for any surgical procedure and adverse outcome in 40%. Conclusion: Secondary hydrocephalus in a premature baby, with LBW, especially if admitted to NICU for more than 1 month, with presence of systemic sepsis and CSF infection by G-ve bacilli especially with frequent CSF tapping had the worst outcome. While maturity and normal birth weight without NICU admission, and absence of sepsis with negative CSF culture predicting a favorable clinical and surgical outcome.
{"title":"Prognostic factors affecting the surgical outcome of secondary hydrocephalus in infants","authors":"Mohamed Elmaghrabi, Waleed Badawy, Mohammed Eltantawy, Heba Abdelhady, Shawky Elmeleigy","doi":"10.21608/bmfj.2023.234928.1894","DOIUrl":"https://doi.org/10.21608/bmfj.2023.234928.1894","url":null,"abstract":": Background: Acquired Hydrocephalus can develop at birth or in adulthood. It has many etiologies like obstruction by Tumors, inflammatory and infective lesions like meningioencephalitis and cerebral abscess. It may result from Hemorrhage like parenchymal hemorrhage, intra-ventricular hemorrhage, germinal matrix hemorrhage(GMH). GMH is the leading cause of acquired infantile hydrocephalus in preterms. But still the main causes of secondary hydrocephalus in the infantile age groups post-meningetic and post hemorrhagic. Aim: the aim of this study is to evaluate the different prognostic factors affecting the clinical and surgical outcome in cases of secondary hydrocephalus in infants. Methods: This is a prospective study conducted on 30 non-consecutive cases with secondary hydrocephalus who underwent surgery by variable surgical procedures at Benha University Hospital from March 2022 to June 2023. Results: The mean age of the included patients was 11.43 months. The distribution of underlying pathology of studied cases was (Post-meningetic 80%, Post-hemorrhagic 13.3%, Post-tumor 6.7%). Cases were followed up for 6-12 months. There was reported incidence of favorable clinical and surgical outcome of 60 % of cases with no need for any surgical procedure and adverse outcome in 40%. Conclusion: Secondary hydrocephalus in a premature baby, with LBW, especially if admitted to NICU for more than 1 month, with presence of systemic sepsis and CSF infection by G-ve bacilli especially with frequent CSF tapping had the worst outcome. While maturity and normal birth weight without NICU admission, and absence of sepsis with negative CSF culture predicting a favorable clinical and surgical outcome.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post Placental Insertion of Different Types of Intrauterine Device During Cesarean Section versus Delayed Intrauterine Device Insertion in Sharkia Governorate Sharkia省剖宫产术中不同类型宫内节育器后胎盘植入与延迟宫内节育器植入的比较
Pub Date : 2023-10-14 DOI: 10.21608/bmfj.2023.233204.1886
Waleed Tawfik, AMAL AMIN, Mahmoud Fayed, Yousef Abdelzaher
: Background: An intrauterine device (IUD) is a small, often T-shaped birth control device that is inserted into the uterus to prevent pregnancy. IUDs are one form of long-acting reversible birth control (LARC). This study's objective was to compare between post placental insertions of different types of IUD (PPIUD) during cesarean section versus delayed IUD (DIUD) insertion. Methods: This prospective interventional study was conducted on 300 women who delivered via uncomplicated cesarean section and seeking IUD contraception. Patients were divided into two equal groups: PPIUD group: women received post placental insertion of different types of IUD (50 received copper T, 50 received Nova T, and 50 received multiload). DIUD Group: women received delayed insertion of different types of IUD (50 received copper T, 50 received Nova T, and 50 received multiload). Results: At 12 months follow-up there was no statistically significant difference between the 2 groups as regards complications. As regards satisfaction rates, 129 were satisfied with the IUD in the DIUD group, and 118 were satisfied with the IUD in PPIUD, and this difference was not statistically significant (p >0.05). Prevalence of outcomes according to type of device in patients in DIUD group, data was insignificant in all outcomes except bleeding. Conclusions: Post-placental insertion of IUD during a cesarean section appears to be a more effective and convenient method of contraception compared to delayed insertion of an IUD. This study showed that post-placental IUD insertion is associated with lower rates of expulsion, thread visibility and menorrhagia compared to delayed insertion.
{"title":"Post Placental Insertion of Different Types of Intrauterine Device During Cesarean Section versus Delayed Intrauterine Device Insertion in Sharkia Governorate","authors":"Waleed Tawfik, AMAL AMIN, Mahmoud Fayed, Yousef Abdelzaher","doi":"10.21608/bmfj.2023.233204.1886","DOIUrl":"https://doi.org/10.21608/bmfj.2023.233204.1886","url":null,"abstract":": Background: An intrauterine device (IUD) is a small, often T-shaped birth control device that is inserted into the uterus to prevent pregnancy. IUDs are one form of long-acting reversible birth control (LARC). This study's objective was to compare between post placental insertions of different types of IUD (PPIUD) during cesarean section versus delayed IUD (DIUD) insertion. Methods: This prospective interventional study was conducted on 300 women who delivered via uncomplicated cesarean section and seeking IUD contraception. Patients were divided into two equal groups: PPIUD group: women received post placental insertion of different types of IUD (50 received copper T, 50 received Nova T, and 50 received multiload). DIUD Group: women received delayed insertion of different types of IUD (50 received copper T, 50 received Nova T, and 50 received multiload). Results: At 12 months follow-up there was no statistically significant difference between the 2 groups as regards complications. As regards satisfaction rates, 129 were satisfied with the IUD in the DIUD group, and 118 were satisfied with the IUD in PPIUD, and this difference was not statistically significant (p >0.05). Prevalence of outcomes according to type of device in patients in DIUD group, data was insignificant in all outcomes except bleeding. Conclusions: Post-placental insertion of IUD during a cesarean section appears to be a more effective and convenient method of contraception compared to delayed insertion of an IUD. This study showed that post-placental IUD insertion is associated with lower rates of expulsion, thread visibility and menorrhagia compared to delayed insertion.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135805629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Comparison of Non-descent Vaginal Hysterectomy and Total Laparoscopic Hysterectomy for Bulky Uterine Fibroids 非下降阴道子宫切除术与腹腔镜全子宫切除术治疗大体积子宫肌瘤的回顾性比较
Pub Date : 2023-10-11 DOI: 10.21608/bmfj.2023.230958.1881
Ashraf Elmantwea, Aziza Negm, Yehia Edris
{"title":"Retrospective Comparison of Non-descent Vaginal Hysterectomy and Total Laparoscopic Hysterectomy for Bulky Uterine Fibroids","authors":"Ashraf Elmantwea, Aziza Negm, Yehia Edris","doi":"10.21608/bmfj.2023.230958.1881","DOIUrl":"https://doi.org/10.21608/bmfj.2023.230958.1881","url":null,"abstract":"","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136213543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MATERNAL AND PERINATAL OUTCOME OF PREGNANT WOMEN WITH PCR CONFIRMED COVID-19 INFECTION IN THIRD TRIMESTER AND ITS EFFECT ON IUGR AND NEONATAL OUTCOME PCR证实的妊娠晚期COVID-19感染孕妇的孕产妇和围产期结局及其对胎儿和新生儿结局的影响
Pub Date : 2023-10-11 DOI: 10.21608/bmfj.2023.196558.1768
Azza Abd El-Khalek, Mohamed Farag, Khaled Salama, Ali Bendary, Rania Abd El-Aty
Background: The potential hazards of the COVID-19 coronavirus illness have prompted considerable caution. Pregnant women's clinical, radiological, and neonatal data can reveal serious issues such as pneumonia. Aim and objectives: to assess third-trimester COVID-19-infected mothers' and third-trimester babies' outcomes by comparing COVID-19-infected pregnant women to those without infection. Subjects and methods: One hundred pregnant women were split into two groups for this prospective observational study at Benha University Hospitals' obstetrics and gynecology department: Group (A) (Case Group): involved 50 pregnant women with a confirmed diagnosis of COVID-19; Group (B) (Control Group): included 50 normal pregnant women without a confirmed COVID-19 infection for at least 3 months. Result : There was a significant difference regarding maternal outcomes in both study groups. Conclusion: There is insufficient evidence to conclude that SARS-CoV-2 infection boosts the chances of maternal complications and fetal and neonatal problems. However, in this study, we found that difficult breast feeding and NICU admission were increasing in patients with COVID-19, which suggests the need for investigation of cystosis, lymph node enlargement, WBCs, and CRP to lower the risk of adverse outcomes.
{"title":"MATERNAL AND PERINATAL OUTCOME OF PREGNANT WOMEN WITH PCR CONFIRMED COVID-19 INFECTION IN THIRD TRIMESTER AND ITS EFFECT ON IUGR AND NEONATAL OUTCOME","authors":"Azza Abd El-Khalek, Mohamed Farag, Khaled Salama, Ali Bendary, Rania Abd El-Aty","doi":"10.21608/bmfj.2023.196558.1768","DOIUrl":"https://doi.org/10.21608/bmfj.2023.196558.1768","url":null,"abstract":"Background: The potential hazards of the COVID-19 coronavirus illness have prompted considerable caution. Pregnant women's clinical, radiological, and neonatal data can reveal serious issues such as pneumonia. Aim and objectives: to assess third-trimester COVID-19-infected mothers' and third-trimester babies' outcomes by comparing COVID-19-infected pregnant women to those without infection. Subjects and methods: One hundred pregnant women were split into two groups for this prospective observational study at Benha University Hospitals' obstetrics and gynecology department: Group (A) (Case Group): involved 50 pregnant women with a confirmed diagnosis of COVID-19; Group (B) (Control Group): included 50 normal pregnant women without a confirmed COVID-19 infection for at least 3 months. Result : There was a significant difference regarding maternal outcomes in both study groups. Conclusion: There is insufficient evidence to conclude that SARS-CoV-2 infection boosts the chances of maternal complications and fetal and neonatal problems. However, in this study, we found that difficult breast feeding and NICU admission were increasing in patients with COVID-19, which suggests the need for investigation of cystosis, lymph node enlargement, WBCs, and CRP to lower the risk of adverse outcomes.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136213113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adoption of Transradial Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction and Its Association with Door-To-Balloon Time 经桡动脉经皮冠状动脉介入治疗ST段抬高型心肌梗死及其与门到球囊时间的关系
Pub Date : 2023-10-02 DOI: 10.21608/bmfj.2023.218914.1843
Mostafa Zahran, Khaled El Rabat, Yaser Abd El Rahman, Ashraf Abd El Mageed, Amr El Nagar
Background: Access-site bleeding is the most frequent bleeding complication of transfemoral primary percutaneous coronary intervention (TF-PPCI). In contrast, transradial PPCI (TR-PPCI) has been demonstrated in multiple trials to be safer than the femoral approach due to the lower risk of significant bleeding. This study's objective was to study adoption of TR-PPCI for STEMI and its association with door‐to‐balloon time (D2BT). Methods: This study was carried out on 70 patients diagnosed as STEMI treated with PPCI were compared according to the access site used during the procedure. Patients were divided into 2 equal groups, group I: STEMI patients treated with TR-PPCI, and group II: STEMI patients treated with TF-PPCI. Patients were subjected to physical examination, risk assessment, electrocardiogram (ECG), transthoracic echocardiography, and coronary angioplasty. Results: D2BT was 107 min in TF-PPCI compared to 114 min in TF-PPCI group with no statistically significant difference. BMI and presence of prior peripheral arterial disease were significantly higher in TR-PPCI group compared to TF-PPCI group. Presence of cardiogenic shock and cardiac arrest within prior 24 h, and mean contrast volume were significantly lower in TR-PPCI group compared to TF-PPCI group ( p ≤ 0.05). Clinical data, ECG, laboratory data, patients’ presenting location, time in minutes, procedural medications, angiographic data, thrombus aspiration device, balloon angioplasty, direct stenting, number and type of stents, TIMI pre and post, and complications were insignificantly different between the studied groups. Conclusions: TR-PPCI can be successfully implemented without compromising D2BT performance offering the potential to improve STEMI outcomes if widely embraced.
{"title":"Adoption of Transradial Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction and Its Association with Door-To-Balloon Time","authors":"Mostafa Zahran, Khaled El Rabat, Yaser Abd El Rahman, Ashraf Abd El Mageed, Amr El Nagar","doi":"10.21608/bmfj.2023.218914.1843","DOIUrl":"https://doi.org/10.21608/bmfj.2023.218914.1843","url":null,"abstract":"Background: Access-site bleeding is the most frequent bleeding complication of transfemoral primary percutaneous coronary intervention (TF-PPCI). In contrast, transradial PPCI (TR-PPCI) has been demonstrated in multiple trials to be safer than the femoral approach due to the lower risk of significant bleeding. This study's objective was to study adoption of TR-PPCI for STEMI and its association with door‐to‐balloon time (D2BT). Methods: This study was carried out on 70 patients diagnosed as STEMI treated with PPCI were compared according to the access site used during the procedure. Patients were divided into 2 equal groups, group I: STEMI patients treated with TR-PPCI, and group II: STEMI patients treated with TF-PPCI. Patients were subjected to physical examination, risk assessment, electrocardiogram (ECG), transthoracic echocardiography, and coronary angioplasty. Results: D2BT was 107 min in TF-PPCI compared to 114 min in TF-PPCI group with no statistically significant difference. BMI and presence of prior peripheral arterial disease were significantly higher in TR-PPCI group compared to TF-PPCI group. Presence of cardiogenic shock and cardiac arrest within prior 24 h, and mean contrast volume were significantly lower in TR-PPCI group compared to TF-PPCI group ( p ≤ 0.05). Clinical data, ECG, laboratory data, patients’ presenting location, time in minutes, procedural medications, angiographic data, thrombus aspiration device, balloon angioplasty, direct stenting, number and type of stents, TIMI pre and post, and complications were insignificantly different between the studied groups. Conclusions: TR-PPCI can be successfully implemented without compromising D2BT performance offering the potential to improve STEMI outcomes if widely embraced.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135901896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of urinary fractional excretion of sodium in resistant hypertension patients 尿钠分数排泄在顽固性高血压患者中的作用
Pub Date : 2023-10-02 DOI: 10.21608/bmfj.2023.216159.1836
Hager Allam, Khaled El-Din, Mohammed Hamouda, Hassan Almekawy
{"title":"Role of urinary fractional excretion of sodium in resistant hypertension patients","authors":"Hager Allam, Khaled El-Din, Mohammed Hamouda, Hassan Almekawy","doi":"10.21608/bmfj.2023.216159.1836","DOIUrl":"https://doi.org/10.21608/bmfj.2023.216159.1836","url":null,"abstract":"","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135901921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Presepsin Versus CRP and Procalcitonin as Biomarker of Sepsis: A meta-analysis 高血压素与CRP和降钙素原作为脓毒症的生物标志物:一项荟萃分析
Pub Date : 2023-10-02 DOI: 10.21608/bmfj.2023.212836.1826
Fatma Abd-El-Fatah, Ahmad Abd-Elhamid, Alyaa Mahfouz, Emad Rezk
Background: Despite advances in therapy, sepsis is the leading cause of death in critical care settings, so early diagnosis of sepsis is a must, so we performed a meta-analysis to compare the accuracy of presepsin versus CRP and procalcitonin as biomarker of sepsis. Methods: This analysis performed using MEDLINE, EMBASE, PubMed and Cochrane to identify all published randomized, and prospective clinical trials, comparing the accuracy of Presepsin versus Procalcitonin and CRP in diagnosis of sepsis. Results: The Database of our meta-analysis included 13 studies with 2679 participants meeting definitive criteria of sepsis, The pooled sensitivity and of presepsin, procalcitonin and CRP was 0.84, 0.80, 0.69 respectively which shows that presepsin is stronger than procalcitonin and CRP, the pooled specificity of presepsin, procalcitonin, CRP was 0.73, 0.69, 0.68 respectively. The PLR and NLR of presepsin were 2.7 and 0.2, respectively and of procalcitonin were 2.6 and 0.29, respectively and of CRP were 2.6 and 0.41, respectively. The DOR of presepsin, procalcitonin and CRP was 11.8, 8.8, 6.2, respectively. Conclusions: This study demonstrated that presepsin is a reliable biomarker of sepsis because of its higher sensitivity and specificity than procalcitonin and CRP.
{"title":"Presepsin Versus CRP and Procalcitonin as Biomarker of Sepsis: A meta-analysis","authors":"Fatma Abd-El-Fatah, Ahmad Abd-Elhamid, Alyaa Mahfouz, Emad Rezk","doi":"10.21608/bmfj.2023.212836.1826","DOIUrl":"https://doi.org/10.21608/bmfj.2023.212836.1826","url":null,"abstract":"Background: Despite advances in therapy, sepsis is the leading cause of death in critical care settings, so early diagnosis of sepsis is a must, so we performed a meta-analysis to compare the accuracy of presepsin versus CRP and procalcitonin as biomarker of sepsis. Methods: This analysis performed using MEDLINE, EMBASE, PubMed and Cochrane to identify all published randomized, and prospective clinical trials, comparing the accuracy of Presepsin versus Procalcitonin and CRP in diagnosis of sepsis. Results: The Database of our meta-analysis included 13 studies with 2679 participants meeting definitive criteria of sepsis, The pooled sensitivity and of presepsin, procalcitonin and CRP was 0.84, 0.80, 0.69 respectively which shows that presepsin is stronger than procalcitonin and CRP, the pooled specificity of presepsin, procalcitonin, CRP was 0.73, 0.69, 0.68 respectively. The PLR and NLR of presepsin were 2.7 and 0.2, respectively and of procalcitonin were 2.6 and 0.29, respectively and of CRP were 2.6 and 0.41, respectively. The DOR of presepsin, procalcitonin and CRP was 11.8, 8.8, 6.2, respectively. Conclusions: This study demonstrated that presepsin is a reliable biomarker of sepsis because of its higher sensitivity and specificity than procalcitonin and CRP.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135901923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CHA2DS2 VASc score and its correlation with TIMI flow count in patients with STEMI Undergoing primary PCI STEMI行初次PCI患者CHA2DS2 VASc评分及其与TIMI血流计数的相关性
Pub Date : 2023-10-02 DOI: 10.21608/bmfj.2023.214627.1831
Al Shimaa M. Sabry, Osama S. Arafa, Mohammed A. Barakat, Mohamed M. Ali
Background: CHA2DS2-VASc score is used to predict the risk of thrombo-embolic events in patients with AF. In this study, CHA2DS2-VASc score was investigated to show its correlation with TIMI flow count among patients with ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Patients & Methods: A total number 106 patients with STEMI were included in this study. Patients were divided into two groups as control group (TIMI III flow) (n= 69) and no-reflow group (n= 37). CHA2DS2-VASc score was calculated and a cut off value of >2 was used as a predictor of TIMI flow count. Results: The no-reflow patients were significantly older with higher prevalence of DM and HTN. Multivariate regression analysis showed that CHA2DS2-VASc score is a significant independent predictor of the no-reflow. Conclusions: CHA2DS2-VASc score is as an easy, fast and independent predictor of TIMI flow count after primary PCI.
{"title":"CHA2DS2 VASc score and its correlation with TIMI flow count in patients with STEMI Undergoing primary PCI","authors":"Al Shimaa M. Sabry, Osama S. Arafa, Mohammed A. Barakat, Mohamed M. Ali","doi":"10.21608/bmfj.2023.214627.1831","DOIUrl":"https://doi.org/10.21608/bmfj.2023.214627.1831","url":null,"abstract":"Background: CHA2DS2-VASc score is used to predict the risk of thrombo-embolic events in patients with AF. In this study, CHA2DS2-VASc score was investigated to show its correlation with TIMI flow count among patients with ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Patients & Methods: A total number 106 patients with STEMI were included in this study. Patients were divided into two groups as control group (TIMI III flow) (n= 69) and no-reflow group (n= 37). CHA2DS2-VASc score was calculated and a cut off value of >2 was used as a predictor of TIMI flow count. Results: The no-reflow patients were significantly older with higher prevalence of DM and HTN. Multivariate regression analysis showed that CHA2DS2-VASc score is a significant independent predictor of the no-reflow. Conclusions: CHA2DS2-VASc score is as an easy, fast and independent predictor of TIMI flow count after primary PCI.","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135901925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease. 胎儿素a在非酒精性脂肪肝严重程度诊断和评估中的无创生物标志物作用
Pub Date : 2023-10-02 DOI: 10.21608/bmfj.2023.226193.1869
Badawy Abdulaziz, Mohamed abd elhamid, Mohamed Elhoseeny, Haitham Mostafa, Radwa Elsharaby, Ghadeer Rashad
{"title":"Role of Fetuin-A as a Noninvasive Biomarker in Diagnosis and Assessment of Severity of Non-Alcoholic Fatty Liver Disease.","authors":"Badawy Abdulaziz, Mohamed abd elhamid, Mohamed Elhoseeny, Haitham Mostafa, Radwa Elsharaby, Ghadeer Rashad","doi":"10.21608/bmfj.2023.226193.1869","DOIUrl":"https://doi.org/10.21608/bmfj.2023.226193.1869","url":null,"abstract":"","PeriodicalId":8803,"journal":{"name":"Benha Veterinary Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135901926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Benha Veterinary Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1